Phase 2 Early Alzheimer's Disease trials recruiting now

All Early Alzheimer's Disease trials, every phase

Phase 2 Early Alzheimer's Disease trials

• A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
  NCT07033494 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 80 locations
• A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
  NCT07252440 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · 1 location
• Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
  NCT07512362 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.